Seaport Therapeutics, Inc. Common Stock
Status: Publicly traded
Direct answer
Seaport Therapeutics, Inc. Common Stock is publicly traded on NASDAQ under the ticker SPTX.
Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform. The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme...
Can you invest in Seaport Therapeutics, Inc. Common Stock?
Yes. Seaport Therapeutics, Inc. Common Stock is publicly traded on NASDAQ under the ticker SPTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Seaport Therapeutics, Inc. Common Stock
Detailed equity research is provided by MarketSnap.